TriSalus Life Sciences In... (TLSI)
TriSalus Life Sciences Statistics
Share Statistics
TriSalus Life Sciences has 37.84M shares outstanding. The number of shares has increased by 12.27% in one year.
| 37.84M |
| 12.27% |
| 0% |
| 8.85% |
| 15.83M |
| 229 |
| 0.46% |
Short Selling Information
The latest short interest is 109.04K, so 0.29% of the outstanding shares have been sold short.
| 109.04K |
| 0.29% |
| 0.45% |
| 2.95 |
Valuation Ratios
The PE ratio is -4 and the forward PE ratio is -31.24. TriSalus Life Sciences's PEG ratio is 0.09.
| -4 |
| -31.24 |
| 4.51 |
| 1.4 |
| -5.13 |
| -3.22 |
| 0.09 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for TriSalus Life Sciences.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of -0.91.
| 2.02 |
| 1.63 |
| -0.91 |
| -0.65 |
| -0.57 |
| -11.7 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $267,554.55 |
| $-302,118.18 |
| 110 |
| 1.23 |
| 1.01 |
Taxes
| 6K |
| -0.02% |
Stock Price Statistics
The stock price has increased by -15.82% in the last 52 weeks. The beta is 0.47, so TriSalus Life Sciences's price volatility has been higher than the market average.
| 0.47 |
| -15.82% |
| 5.38 |
| 4.92 |
| 52.65 |
| 49,584 |
Income Statement
In the last 12 months, TriSalus Life Sciences had revenue of 29.43M and earned -33.23M in profits. Earnings per share was -1.25.
| 29.43M |
| 25.33M |
| -36.16M |
| -33.23M |
| -36.16M |
| -33.13M |
| -1.25 |
Balance Sheet
The company has 8.53M in cash and 23.63M in debt, giving a net cash position of -15.1M.
| 8.53M |
| 23.63M |
| -15.1M |
| -279.55M |
| 28.63M |
| 13.34M |
Cash Flow
In the last 12 months, operating cash flow was -40.84M and capital expenditures -345K, giving a free cash flow of -41.19M.
| -40.84M |
| -345K |
| -41.19M |
| -1.55 |
Margins
Gross margin is 86.06%, with operating and profit margins of -122.88% and -112.92%.
| 86.06% |
| -122.88% |
| -102.07% |
| -112.92% |
| -122.88% |
| -122.88% |
| -139.95% |
Dividends & Yields
TLSI does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for TLSI is $11, which is 100.7% higher than the current price. The consensus rating is "Buy".
| $11 |
| 100.7% |
| Buy |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -12.93 |
| 2 |